Press
Releases
September
18, 2007 —
Aphios
Awarded STTR Grant from NCI for Nanosomal Formulation of
Novel, Nontoxic Vitamin D Analog for Hormone Refractory
Prostate Cancer
February
19, 2007 —
Aphios
Awarded United States Patent for Polymer Nanospheres Technology
Platform
June
13, 2006 —
Aphios
Awarded United States Patent for Antiviral Therapeutics
May
09, 2006 —
Aphios
Awarded United States Patent for Vaccines for HIV/AIDS,
Influenza and Other Infectious Diseases
February
27, 2006 —Aphios
Corporation Awarded Japanese Patent for Phospholipid Nanosomes
January
18, 2006
— Amyxa
Pharmaceutials to Develop Novel Anti-Influenza Drug from
Marine Microorganisms and Medicinal Plants
January
17, 2006 —
Boston
Buisness Journal: Bird Flu Prompts Local R&D
December
13, 2005
— Aphios
Corporation Announces Licensing of Non-Toxic Vitamin D Analog
for Prostate Cancer from Boston University Medical School
November
14, 2005 —
Mass
High Tech:
Woburn Marine Tech Firm Links with Maine Co., Seeks Growth
Funding
July
19, 2005
— Aphios
Corporation Announces Collaboration with Japanese Companies
for Development of Orally-Bioavilable Anti-Cancer Therapeutic
November
17, 2004—
Aphios Corporation
Announces Launch of SuperCool Gingerol for Calming Stomachs
and Healthy Digestion
July
13, 2004
— Aphios
Corporation Announces Launch of SuperCool St. John for Emotional
Well-Being, Relaxed Outlook and Positive Mood
April
19, 2004
— Mass
High Tech: Nature's Way The Case For, Against Natural Therapeutics
March
23, 2004
— Mass
High Tech: Aphios Wins Substantial NIH Grant to Study Potential
HIV Therapies
March
23, 2004
— Aphios
Corporation Awarded Innovative Research Grant from National
Institute of Allergy & Infectious Diseases, NIH to Develop
Novel Anti-HIV Therapeutics
March
16, 2004
— Aphios
Corporation Executes Material Transfer Agreement with National
Cancer Institute, NIH for Natural Products to Discover and
Develop Novel Anticancer and Antiviral Therapeutics
September
19, 2003
— Natural High:
Aphios Profits by Taming Wild Compounds; Boston Business
Journal
September
09, 2003
— Aphios
Corporation Awarded National Institutes of Health SBIR Grant
to Develop Novel Anti-Smallpox Therapeutics
September
03, 2003
— Aphios
Corporation Executes Cooperative Agreement with NIH and
USAMRID For Discovery of Novel Therapeutics Against SARS
and Other Coronaviruses
June
03, 2003
— Aphios
Corporation Granted United States Patent for Fractionation
of Biologically-Derived Materials
January
07,
2003
— Aphios
Corporation awarded National Institutes of Health Grant
for Development of Novel Anti-Influenza Drugs
December
11, 2002
— Aphios
granted European Patent for Nanoencapsulation of Cancer
Drugs
November
04, 2002
— Aphios
granted US Patent for Inactivating Viruses and Other Pathogens
in Human Plasma and Blood Products
June
13,
2002
— Aphios
Corporation High on Possibility of Treating Hunger Loss;
Woburn Advocate
June
04,
2002
— Aphios
Awarded National Cancer Institute Grant for Developing Natural
Cannabinoid Products for Medical Use
May
07, 2002
— Aphios
Awarded NCI Contract for Manufacturing and Formulation of
Natural Anticancer Drug for Melanoma Clinical Trials
October
24, 2001
— Aphios
Granted United States Patent for Making an Enhanced St.
John’s Wort Product
July
17, 2001
— Aphios
Awarded Contract from National Cancer Institute for Isolation
of Natural Anticancer Drugs
June
20,
2001
— Aphios
and ITC/Immune Technology to Collaborate on Natural Therapuetic
for Chronic Hepatitis C
May
07, 2001
— Aphios
Granted United States Patent for the Crystallization of
Complex Molecules such as Taxol
February
19,
2001
— Time-release
Technology for HIV Vaccine Draws Grant; Mass High Tech
January
29,
2001
— Aphios
Awarded Grant from NIAID, NIH for Development of Controlled
Release HIV Vaccine Adjuvant
December
19, 2000
— Aphios
Awarded SBIR Grant from FDA For Development of a Virus Inactivation
Medical Device
November
28, 2000
— Aphios
Awarded SBIR Grant from NIGMS, NIH for Development of a
Natural Virus-Free Fibrin Sealant
October
10, 2000
— Aphios
awarded SBIR Grant from NIH for Development of Natural Marine
Anti-Plaque Compound
October
03, 2000
— Aphios
awarded SBIR grant from NCCAM, NIH for Standardized &
Improved Saw Palmetto Product
September
13, 2000
— Aphios
Corporation Granted European Patent for Inactivating Viruses
May
23, 2000
— Aphios
Corporation Granted Chinese Patent For Isolation of Taxol®
from Yew Needles
May
11, 2000
— Aphios
Corporation Awarded Phase II SBIR Grant from NCCAM, NIH
for Improved St. John’s Wort Product
November
03, 1999
— Aphios
Corporation Awarded Fast-Track SBIR Grant from NIH for Improved
St. John’s Wort Product
September
28, 1999
— Aphios
Corporation Awarded SBIR Grant from NIH for Solvent-Free
Protein Comminution
June
29, 1999
— Aphios
Corporation Granted United States Patent for Drug Manufacturing
Process Rapidly and Selectively Manufactures Truly “Green”
Medicines
June
02, 1999
— Aphios
Corporation Granted United States Patent for Drug Delivery
Technique Reduces Toxicity and Improves Efficacy of Taxol
®
May
18, 1999
— Aphios
Corporation Granted United States Patent for Virus Inactivation
Drug SafetyTechnique
May
11, 1999
— Aphios
Corporation Granted United States Patent for Drug Discovery
Technique
August
10, 1998
— Aphios
Corporation Granted NIH Support for Development of Novel
HIV Therapeutic Vaccine
